AM Investment Strategies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
AM Investment Strategies's BMY Position: Q2 2026 in Review
AM Investment Strategies increased its Bristol-Myers Squibb (BMY) stake by 0.21% in Q2 2026, buying an estimated $861 and bringing the position to 7,289 shares worth $420K. The position accounts for 0.08% of the portfolio, ranked #81.
AM Investment Strategies first reported a position in BMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $5.35M in Q2 2022. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- AM Investment Strategies held 7,289 shares of Bristol-Myers Squibb worth $420K as of Q2 2026.
- AM Investment Strategies bought 15 Bristol-Myers Squibb shares in Q2 2026, an estimated $861.
- Bristol-Myers Squibb made up 0.08% of AM Investment Strategies's portfolio in Q2 2026, its #81 holding.
- AM Investment Strategies first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 24 quarters since.
- AM Investment Strategies's Bristol-Myers Squibb position peaked at $5.35M in Q2 2022.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on AM Investment Strategies's 13F filing for Q2 2026, filed 16 Jul 2026.